Skip to main content

Table 6 Different HPV subtype infection rates among NILM, AGC, ASC, LSIL, and HSIL, respectively

From: Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014–2019

HPV subtype N NILM (%) N = 19,222 LSIL (%) N = 159 HSIL (%) N = 125 AGC (%) N = 15 ASC (%) N = 4202 Cervical adenocarcinoma (%) N = 1 TCT positive, n (%)
HPV16 555 319 (57.48) 23 (4.14) 51 (9.19) 0 (0) 162 (29.19) 0 (0) 236 (42.52)
HPV18 205 138 (67.32) 7 (3.41) 4 (1.95) 0 (0) 56 (27.32) 0 (0) 67 (32.68)
HPV31 171 118 (69.01) 6 (3.51) 4 (2.34) 0 (0) 43 (25.15) 0 (0) 53 (30.99)
HPV33 255 161 (63.14) 10 (3.92) 13 (5.1) 0 (0) 71 (27.84) 0 (0) 94 (36.86)
HPV35 69 45 (65.22) 4 (5.8) 2 (2.9) 0 (0) 18 (26.09) 0 (0) 24 (34.78)
HPV39 354 252 (71.19) 13 (3.67) 3 (0.85) 1 (0.28) 85 (24.01) 0 (0) 102 (28.81)
HPV45 53 34 (64.15) 1 (1.89) 4 (7.55) 0 (0) 14 (26.42) 0 (0) 19 (35.85)
HPV51 355 256 (72.11) 11 (3.1) 4 (1.13) 1 (0.28) 83 (23.38) 0 (0) 99 (27.89)
HPV52 756 505 (66.8) 27 (3.57) 16 (2.12) 1 (0.13) 207 (27.38) 0 (0) 251 (33.2)
HPV53 373 259 (69.44) 18 (4.83) 6 (1.61) 0 (0) 90 (24.13) 0 (0) 114 (30.56)
HPV56 121 77 (63.64) 8 (6.61) 1 (0.83) 0 (0) 35 (28.93) 0 (0) 44 (36.36)
HPV58 586 398 (67.92) 21 (3.58) 26 (4.44) 1 (0.17) 140 (23.89) 0 (0) 188 (32.08)
HPV59 70 48 (68.57) 4 (5.71) 1 (1.43) 0 (0) 17 (24.29) 0 (0) 22 (31.43)
HPV66 195 135 (69.23) 7 (3.59) 2 (1.03) 0 (0) 51 (26.15) 0 (0) 60 (30.77)
HPV68 192 131 (68.23) 5 (2.6) 2 (1.04) 0 (0) 54 (28.12) 0 (0) 61 (31.77)
HPV6 147 89 (60.54) 7 (4.76) 1 (0.68) 0 (0) 50 (34.01) 0 (0) 58 (39.46)
HPV11 126 89 (70.63) 5 (3.97) 0 (0) 0 (0) 32 (25.4) 0 (0) 37 (29.37)
HPV42 54 33 (61.11) 2 (3.7) 1 (1.85) 0 (0) 18 (33.33) 0 (0) 21 (38.89)
HPV43 26 16 (61.54) 1 (3.85) 1 (3.85) 0 (0) 8 (30.77) 0 (0) 10 (38.46)
HPV44 95 67 (70.53) 1 (1.05) 0 (0) 0 (0) 27 (28.42) 0 (0) 28 (29.47)
HPV81 379 295 (77.84) 9 (2.37) 2 (0.53) 1 (0.26) 72 (19) 0 (0) 84 (22.16)
Total 5137 3465 190 144 5 1333 0 1672
  1. The first 15 were HR-HPV subtypes and the last 6 were LR-HPV subtypes